When Should You Actually Get an Aesthetic Treatment?

Search for almost any visible facial change and the internet will give you a treatment name within seconds.

Forehead line: Botox. Hollow: filler. Soft jawline: filler or tightening. Brown spots: laser. Texture: microneedling. Collagen loss: Sculptra. The answer arrives so quickly that it can feel as though the difficult part of aesthetic medicine is choosing between products.

It is not.

The difficult part is deciding whether a treatment belongs at all, what problem it is being asked to solve, and whether doing it now is more useful than waiting, treating something else first, or leaving the area alone.

That is the part of medical aesthetics that is hardest to shop for because it happens before the syringe, device or treatment room becomes visible.

At skinalchemy in London, Ontario, we formalize that decision through a principle inside the skinalchemy Method called the Treatment Threshold. It is not a score for the patient. It is a standard applied to our own recommendation.

A treatment should enter the plan only when we can defend why it belongs for this patient, at this time, for this reason.

Technically possible is not the same as worth doing

Modern aesthetic medicine can alter an extraordinary number of things.

That technical ability creates a subtle problem. Once something can be treated, it is easy to start thinking of the visible feature as an indication simply because an intervention exists for it.

But a line can be treatable without being worth treating. A hollow can accept filler without filler improving the face. A skin treatment can be performed safely and still be poorly timed. A patient can have enough laxity for an energy-based treatment to create change, but not enough expected change for the cost, recovery or treatment burden to make sense.

The question is not simply, “Can this be treated?”

The more useful question is, “Would treating this meaningfully improve what the patient is actually noticing, without creating a larger problem somewhere else?”

That shift sounds small. In practice, it changes almost everything.

First, the concern has to be understood

Patients usually arrive with observations rather than diagnoses.

“I look tired.” “My lower face feels heavier.” “This line never used to stay.” “My skin looks different.” “Something about my filler feels off.”

Those observations are useful. They tell us where the patient is experiencing change and what matters to them. They do not automatically tell us the mechanism.

A tired appearance around the eyes, for example, may involve pigment, vascular show, skin thickness, adjacent support, true hollowing, fluid tendency, or several of those at once. A heavy lower face may reflect volume distribution, tissue descent, muscle pull, skin laxity, or a previous treatment that changed the relationship between areas.

If the concern has not been read clearly enough, the treatment decision is premature.

This is why a medical aesthetics consultation in London, Ontario should not function as a checkout lane for the service a patient selected online. The booking reason tells us what started the conversation. Assessment determines whether that treatment survives the conversation.

Then the mechanism has to match the problem

Every treatment has a mechanism. That mechanism gives it both usefulness and limits.

Neuromodulators alter selected muscle activity. Hyaluronic acid filler changes volume, support or contour. Sculptra and other biostimulatory approaches work through a collagen response over time. BBL uses light to address selected pigment and vascular targets. Moxi is a non-ablative fractional laser. CoolPeel is fractional CO2 resurfacing.

Potenza combines microneedling with radiofrequency. Focused ultrasound acts at selected tissue depths to address laxity in appropriately selected patients.

Those are not competing versions of the same thing.

A treatment should not be asked to do a job its mechanism cannot reasonably perform.

This is where many disappointing plans begin. The patient identifies the place where the problem is visible. The treatment is selected for that location. Nobody stops to ask whether the visible location is actually where the decision should begin.

The place a change is visible is not always where the decision begins.

The expected improvement has to be meaningful

This is the part that is easy to skip when aesthetic care is organized around a menu.

A small technical improvement is not automatically a good recommendation.

We have to consider what the expected change is likely to mean to the face as a whole, and what the patient has to take on to get it: cost, recovery, maintenance, risk, time, and the possibility of altering something that already works well.

Sometimes a subtle intervention is exactly right because a small change in the correct place restores proportion.

Sometimes a subtle intervention is simply too little benefit to justify the burden.

The Treatment Threshold is not designed to make every plan smaller. A patient with several meaningful contributors may benefit from a substantial plan across multiple categories. Selective does not mean minimal. It means every part of the plan has a reason.

Timing can make a correct treatment wrong

A treatment can belong eventually and still not belong today.

Previous filler may still be affecting the anatomy. A biostimulator may still be developing. Tissue swelling can obscure the read. Skin may need barrier support before energy-based treatment. A first treatment may need time to settle before the next decision becomes clear. A patient’s medical history, medication use, healing capacity or recent health changes may alter readiness.

This is why sequencing matters.

Time is not empty space between appointments. It produces information.

When the first intervention has settled, the face is easier to read. What remains may be smaller than expected, more clearly attributable to another layer, or no longer worth treating. The original second step may still be right. It may also disappear from the plan.

A plan that changes after reassessment is not a failed plan. It is a plan responding to new information.

The plan should protect what already belongs

Assessment should not become a search for defects.

Some movement belongs. Some asymmetry belongs. Some facial characteristics are part of the reason a person looks recognizably like themselves. The ability to soften, fill, tighten or resurface something does not create an obligation to do it.

One of the most important questions in a consultation is not “What could we improve?”

It is “What should remain untouched?”

This is where anatomy and artistry meet. Anatomy narrows what makes clinical sense. Aesthetic judgment decides how far refinement should go and when the better decision is to stop.

We do not change faces. We restore structure.

What can come out of an assessment

The result of a proper assessment is not always a treatment performed that day.

It may be:

• treat now;
• stage treatment over time;
• address a different layer first;
• correct previous treatment first;
• wait for a current treatment to declare its effect;
• preserve the area as it is;
• refer to another provider or specialty;
• reassess later;

• or recommend no treatment at this time.

That range of possible answers is important.

If every consultation reliably ends with the service that was booked, the consultation is not changing the decision very much.

What this means if you are choosing a clinic in London, Ontario

You do not need to become an expert in treatment names before you book.

Bring what you notice. Bring your treatment history. Bring photographs if they help explain the change. Be clear about what you want to preserve, what recovery you can realistically tolerate, and what kind of change would feel meaningful to you.

Then listen closely to how the recommendation is built.

Can the provider explain what appears to be contributing? Can they explain what the proposed treatment can change and what it cannot? Can they tell you why this treatment belongs now rather than simply why the treatment exists? Are they willing to change the plan if the anatomy does not support the service you arrived asking for?

That is the difference between being matched to a menu and being assessed.

At skinalchemy, the treatment is the visible part. The judgment behind it is the part you are actually trusting.

Sonia Vilos, NP is Founder and Medical Director of skinalchemy, a Nurse Practitioner-led medical aesthetics practice in London, Ontario. Treatment decisions are made after individualized assessment, medical history and informed consent.